Developmental considerations in neonatal failure.
D000375:Aging; D000818:Animals; D001775:Blood Circulation; D001833:Body Temperature Regulation; D002302:Cardiac Output; D004070:Digitalis; D004077:Digoxin / Q000097:blood; D004298:Dopamine / Q000627:therapeutic use; D005314:Embryonic and Fetal Development; D005318:Fetal Heart / Q000033:anatomy & histology / Q000502:physiology*; D006331:Heart Diseases / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007545:Isoproterenol / Q000627:therapeutic use; D009638:Norepinephrine / Q000627:therapeutic use; D010101:Oxygen Consumption; D010946:Plants, Medicinal; D010947:Plants, Toxic; D012756:Sheep; D013963:Thyroid Hormones / Q000502:physiology
D013963:Thyroid Hormones; D004077:Digoxin; D007545:Isoproterenol; D004298:Dopamine; D009638:Norepinephrine